Application of fibrinogen concentrate (Fibrinogen HT) to uncontrollable massive bleeding
Not Applicable
- Conditions
- Massive bleeding during 1)Pregnancy and delivery 2)Cardiovascular surgery 3)Gastrointestinal (including hepato-biliary-pancreatic) surgery
- Registration Number
- JPRN-UMIN000022666
- Lead Sponsor
- Kagoshima University Hospital, Division of blood transfusion medicine and cell therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
Patient (or the patient's family) who did not give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Avoidance rate of using fresh allogenic blood obtained in the hospital to uncontrollable massive bleeding
- Secondary Outcome Measures
Name Time Method Survival rate Fibrinogen value before and after the usage of fibrinogen concentrate Blood loss Blood product usage